M. Lobo

Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit

Miguel Martín, M. Cebollero, I. Márquez-Rodas, 2018, Journal of Genetic Counseling.

Long term control stereotactic body radiotherapy (SBRT) for oligometastatic colorectal cancer: a single center study.

C. Camps Herrero, M. Lobo, S. Calabuig-Fariñas, 2020, Chinese clinical oncology.

Complete Response to Chemotherapy in A Patient with Unresectable Extrahepatic Cholangiocarcinoma

C. Camps, M. Lobo, Mahmoud Sayed Ahmed Shahin, 2019, Archives of Clinical and Medical Case Reports.

Cyclin Kinase Inhibitors in Breast Cancer: From Bench to Bedside

Miguel Martín, I. Márquez-Rodas, M. Lobo, 2014, Current Breast Cancer Reports.

Diagnostic-therapeutic management of bile duct cancer

J. Huguet, C. Boix, M. Lobo, 2019, World journal of clinical cases.

Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial

A. Picornell, H. Gómez, J. García-Saenz, 2016, Breast Cancer Research and Treatment.

Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer

J. García-Saenz, F. Moreno, Miguel Martín, 2017, Breast Cancer Research and Treatment.

Five Years of Multidisciplinary Care in Hereditary Cancer: Our Experience in a Spanish University Hospital

M. Martín, I. Márquez-Rodas, M. Lobo, 2016, Oncology.

This is a call to oncologists for action

C. Camps, M. Lobo, A. Berrocal, 2018, Clinical and Translational Oncology.